3847 results for «2273»
3847 results
Rapid-fire abstracts: session 4
27 Nov 2022 – From PCR London Valves 2022
In this PCR LV 2022 session dedicated to TAVI, take advantage of the 7 abstracts to learn more about the impact of TAVI for pure regurgitation on the severity of concomitant mitral regurgitation, the deformation of transcatheter heart valve and haemodynamics after aortic ViV, and much...
Rapid-fire abstracts: Session 8
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of abstracts presented during PCR LV 2022: ultrasound-guided vs. conventional MANTA vascular closure device deployment after TAVR, novel aortic regurgitation quantification after Portico TAVI, mid-term outcome of TAVI using Myval transcatheter heart valve in severe bicuspid aortic stenosis, and...
Innovations in TMVR and Intrepid trial updates
29 Nov 2022 – From PCR London Valves 2022
Watch this session if you want to gain insights on the APOLLO TMVR trial, the Intrepid trial and to hear about future innovations in mitral replacement.
TAVI procedure planning and optimising patient outcomes
21 Nov 2021 – From PCR London Valves 2021
Watch this series of videos from PCR London Valves 2021 to evaluate whether TAVICT scans can replace invasive coronary angiography pre-TAVI, to appreciate how pre-operative computed tomography evaluation of aortic burden can predict acute kidney injury post-TAVR, and to appraise mortality in TAVI patients converted to...
The Navitor with FlexNav TAVI system: when smooth implantability allows to optimise TAVI outcomes
21 Nov 2021 – From PCR London Valves 2021
In this session from the PCR London Valves 2021 Congress, find out more about the new Navitor valve and FlexNav delivery system, discover how to achieve favourable patient outcomes, and learn how choosing a device can impact patient lifetime management.
Outcomes after novel transcatheter and surgical tricuspid valve interventions
21 Nov 2021 – From PCR London Valves 2021
Find out more about TRI-SCORE, a new risk score to predict in-hospital mortality after isolated tricuspid valve surgery, 30-day outcomes for transcatheter tricuspid repair from the TriBAND study, both the CLASP TR early feasibility and TRISCEND studies six-month results, and more in this PCR London Valves...
Transcatheter mitral valve replacement: patient selection and hemodynamic stability
22 Nov 2021 – From PCR London Valves
Watch this session broadcast at PCR London Valves 2021 to find out more about TMVR as a novel treatment option for patients with mitral disease, to learn how to identify the right candidate for TMVR, and to understand how to best medically manage patients peri-procedurally.
Outcomes following transcatheter and percutaneous mitral valve repair
21 Nov 2021 – From PCR London Valves 2021
CLASP study, predictability of post-delivery residual mitral regurgitation, MiCLASP PMCF study, off-pump transapical neochord implantation, pronostic impact of nutritional status, and patients with low, intermediate and high frailty are the focus of this session from PCR LV 2021 devoted to percutaneous and transcatheter mitral valve repair.
Obtaining commissural alignment in TAVI
23 Nov 2021 – From PCR London Valves 2021
Watch this session from PCR London Valves 2021 about the importance of commissural alignment in TAVI to know how to achieve commissural alignment with different TAVI systems, and to discover a step-by-step demonstration of patient-specific commissural alignment with the ACURATE neo2 THV system.
Lifetime management of patients with severe aortic stenosis
22 Nov 2021 – From PCR London Valves
Don't miss this PCR London Valves 2021 session if you wish to discuss the importance of lifetime management in patients with severe aortic stenosis, to learn about the latest CoreLab adjudicated outcomes from the Early neo2 registry, and to understand how valve design, implant technique, embolic...
Transcatheter mitral, aortic and pulmonary valve implantation
21 Nov 2021 – From PCR London Valves 2021
Watch this series of videos from PCR London Valves 2021 to learn about acute heart failure hospitalizations following TAVI in the U.S., share a peripheral hospital's experiences with structural valve service modernization, enjoy percutaneous transseptal mitral valve implantation in Brazil, and more!
Seeing is believing: predictable and durable treatment of mitral regurgitation across etiologies with the PASCAL platform
23 Nov 2021 – From PCR London Valves
Explore the clinical impact of the Edwards portfolio of transcatheter devices for mitral regurgitation treatment in this PCR London Valves 2021 session that you shouldn't miss if you want to attend case-based discussions that will analyze key PASCAL features to treat mitral regurgitation and to participate...
Miscellaneous - Paravalvular leak closure, PFO closure and LAA occlusion
21 Nov 2021 – From PCR London Valves 2021
Want to know more about the impact of baseline PFO anatomy on residual right to left shunt after transcatheter closure, transcatheter closure of paravalvular leak, or even percutaneous mitral paravalvular leak closure using CT planning? This PCR London Valves 2021 session is for you!
From TAVI to mitral and tricuspid - Applying evidence to expand patients' treatment options
21 Nov 2021 – From PCR London Valves 2021
Nowadays, there is an increasing range of treatment options as far as tricuspid and mitral regurgitations are concerned. Bernard Prendergast, Philipp Lurz, Fabien Praz and Maurizio Taramasso discuss the challenges and needs regarding mitral and tricuspid valve disease treatment. They also consider what is needed to...
PCR London Valves 2021 Hotlines / Late-Breaking Trials: bRIGHT, EXPAND, CHOICE-MI
21 Nov 2021 – From PCR London Valves
Real-world outcomes for tricuspid edge-to-edge repair, predictors of heart failure hospitalisation and its impact on clinical outcomes, one-year outcomes after TMVI... View part of the Late-Breaking Trials presented during PCR London Valves 2021.
From TAVI to mitral and tricuspid - Applying evidence to expand patients' treatment options - Part 1 - Best long-term outcomes start with the first procedure
21 Nov 2021 – From PCR London Valves
In this session from PCR London Valve 2021 dedicated to TAVI, mitral, and tricuspid, let's examine the issues related to the lifetime patient journey faced by many patients, starting with an analysis of severe aortic stenosis: how to identify the most important factors when considering the...
From TAVI to mitral and tricupid - Applying evidence to expand patients' treatment options - Part 2 - Securing long-term patient options
22 Nov 2021 – From PCR London Valves
Nowadays, there is an increasing range of treatment options as far as tricuspid and mitral regurgitations are concerned, as you can notice in this session broadcast at PCR London Valves 2021 Congress, focusing on this topic area. Watch it now if you wish to understand how key...
Innovation and imaging guidance for tricuspid valve replacement
21 Nov 2021 – From PCR London Valves
Watch this TNT session broadcast at PCR London Valves 2021 Congress to learn more about the crucial importance of understanding imaging and having high-quality imaging to guide transcatheter tricuspid valve intervention.
SURTAVI five-year outcomes - What do you need to know considering the new ESC guidelines?
21 Nov 2021 – From PCR London Valves 2021
Join Nicolas Van Mieghem, Nicole Karam and Thomas Modine to learn more about about SURTAVI five-year study outcomes and to discover which factors are impacting valve performance overtime.
Cusp overlap technique - How it evolved my practice?
21 Nov 2021 – From PCR London Valves 2021
Join Darren Mylotte, Derk Frank and Vincent Roolvink if you want to discover real-life practices with the Cusp Overlap technique, as well as to learn about its adoption benefits and its essentials procedural steps.
